{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:16:44Z","timestamp":1760955404867},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T00:00:00Z","timestamp":1360195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1038\/hr.2012.231","type":"journal-article","created":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T07:00:33Z","timestamp":1360220433000},"page":"520-527","source":"Crossref","is-referenced-by-count":6,"title":["Coupling factor 6 enhances the spontaneous microaggregation of platelets by decreasing cytosolic cAMP irrespective of antiplatelet therapy"],"prefix":"10.1038","volume":"36","author":[{"given":"Takanori","family":"Sukekawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Osanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumie","family":"Nishizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norifumi","family":"Metoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joji","family":"Hagii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaatsu","family":"Kamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Yasujima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Magota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,7]]},"reference":[{"key":"BFhr2012231_CR1","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.2337\/diacare.26.7.2181","volume":"26","author":"JA Colwell","year":"2003","unstructured":"Colwell JA, Nesto RW . The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care 2003; 26: 2181\u20132188.","journal-title":"Diabetes Care"},{"key":"BFhr2012231_CR2","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/j.1538-7836.2004.00836.x","volume":"2","author":"P Ferroni","year":"2004","unstructured":"Ferroni P, Basili S, Falco A, Dav\u00ec G . Platelet activation in type 2 diabetes mellitus. J Thromb Haemost 2004; 2: 1282\u20131291.","journal-title":"J Thromb Haemost"},{"key":"BFhr2012231_CR3","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nm1102-1227","volume":"8","author":"ZM Ruggeri","year":"2002","unstructured":"Ruggeri ZM . Platelets in atherothrombosis. Nat Med 2002; 8: 1227\u20131234.","journal-title":"Nat Med"},{"key":"BFhr2012231_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0049-3848(96)00026-6","volume":"81","author":"K Satoh","year":"1996","unstructured":"Satoh K, Ozaki Y, Qi R, Yang L, Asazuma N, Yatomi Y, Kume S . Factors that affect the size of platelet aggregates in epinephrine-induced activation: a study using the particle counting method based upon light scattering. Thromb Res 1996; 81: 515\u2013523.","journal-title":"Thromb Res"},{"key":"BFhr2012231_CR5","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1056\/NEJM199005313222201","volume":"322","author":"MD Trip","year":"1990","unstructured":"Trip MD, Cats VM, van Capelle FJ, Vreeken J . Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990; 322: 1549\u20131554.","journal-title":"N Engl J Med"},{"key":"BFhr2012231_CR6","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1161\/01.HYP.0000186483.86750.85","volume":"46","author":"T Osanai","year":"2005","unstructured":"Osanai T, Magota K, Tanaka M, Shimada M, Murakami R, Sasaki S, Tomita H, Maeda N, Okumura K . Intracellular signaling for vasoconstrictor coupling factor 6: novel function of \u03b2-subunit of ATP synthase as receptor. Hypertension 2005; 46: 1140\u20131146.","journal-title":"Hypertension"},{"key":"BFhr2012231_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature01250","volume":"421","author":"LO Martinez","year":"2003","unstructured":"Martinez LO, Jacquet S, Esteve JP, Rolland C, Cabezon E, Champagne E, Pineau T, Georgeaud V, Walker JE, Terce F, Collet X, Perret B, Barbaras R . Ectopic \u03b2-chain of ATP synthase is an apolopoprotein A-I receptor in hepatic HDL endocytosis. Nature 2003; 421: 75\u201379.","journal-title":"Nature"},{"key":"BFhr2012231_CR8","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1073\/pnas.96.6.2811","volume":"96","author":"TL Moser","year":"1999","unstructured":"Moser TL, Stack MS, Asplin I, Enghild JJ, Hojrup P, Everitt L, Hubchak S, Schnaper HW, Pizzo SV . Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA 1999; 96: 2811\u20132816.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFhr2012231_CR9","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1073\/pnas.131067798","volume":"98","author":"TL Moser","year":"2001","unstructured":"Moser TL, Kenan DJ, Ashley TA, Roy JA, Goodman MD, Misra UK, Cheek DJ, Pizzo SV . Endothelial cell surface F1-Fo ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci USA 2001; 98: 6656\u20136661.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFhr2012231_CR10","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1161\/hc5001.100832","volume":"104","author":"T Osanai","year":"2001","unstructured":"Osanai T, Okada S, Sirato K, Nakano T, Saitoh M, Magota K, Okumura K . Mitochondrial coupling factor 6 is present on the surface of human vascular endothelial cells and released by shear stress. Circulation 2001; 104: 3132\u20133136.","journal-title":"Circulation"},{"key":"BFhr2012231_CR11","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.cardiores.2004.01.031","volume":"62","author":"S Sasaki","year":"2004","unstructured":"Sasaki S, Osanai T, Tomita H, Matsunaga T, Magota K, Okumura K . Tumor necrosis factor \u03b1 as an endogenous stimulator for circulating coupling factor 6. Cardiovasc Res 2004; 62: 578\u2013586.","journal-title":"Cardiovasc Res"},{"key":"BFhr2012231_CR12","doi-asserted-by":"publisher","first-page":"31778","DOI":"10.1074\/jbc.273.48.31778","volume":"273","author":"T Osanai","year":"1998","unstructured":"Osanai T, Kamada T, Fujiwara N, Katoh T, Takahashi K, Kimura M, Satoh K, Magota K, Kodama S, Tanaka T, Okumura K . A novel inhibitory effect on prostacyclin synthesis of coupling factor 6 extracted from the heart of spontaneously hypertensive rats. J Biol Chem 1998; 273: 31778\u201331783.","journal-title":"J Biol Chem"},{"key":"BFhr2012231_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/01.hjh.0000209985.66853.1e","volume":"24","author":"M Tanaka","year":"2006","unstructured":"Tanaka M, Osanai T, Murakami R, Sasaki S, Tomita H, Maeda N, Satoh K, Magota K, Okumura K . Effect of vasoconstrictor coupling factor 6 on gene expression profile in human vascular endothelial cells: enhanced release of asymmetric dimethylarginine. J Hypertens 2006; 24: 489\u2013497.","journal-title":"J Hypertens"},{"key":"BFhr2012231_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2007.12.010","volume":"200","author":"A Kumagai","year":"2008","unstructured":"Kumagai A, Osanai T, Katoh C, Tanaka M, Tomita H, Morimoto T, Murakami R, Magota K, Okumura K . Coupling factor 6 downregulates platelet endothelial cell adhesion molecule-1 via c-Src activation and acts as a proatherogenic molecule. Atherosclerosis 2008; 200: 45\u201350.","journal-title":"Atherosclerosis"},{"key":"BFhr2012231_CR15","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1172\/JCI11076","volume":"108","author":"T Osanai","year":"2001","unstructured":"Osanai T, Tanaka M, Kamada T, Nakano T, Takahashi K, Okada S, Sirato K, Magota K, Kodama S, Okumura K . Mitochondrial coupling factor 6 as a novel endogenous vasoconstrictor. J Clin Invest 2001; 108: 1023\u20131030.","journal-title":"J Clin Invest"},{"key":"BFhr2012231_CR16","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/cvr\/cvn356","volume":"81","author":"T Osanai","year":"2009","unstructured":"Osanai T, Tomita H, Kushibiki M, Yamada M, Tanaka M, Ashitate T, Echizen T, Katoh C, Magota K, Okumura K . Coupling factor 6 enhances Src-mediated responsiveness to angiotensin II in resistance arterioles and cells. Cardiovasc Res 2009; 81: 780\u2013787.","journal-title":"Cardiovasc Res"},{"key":"BFhr2012231_CR17","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1097\/00004872-200312000-00021","volume":"21","author":"T Osanai","year":"2003","unstructured":"Osanai T, Sasaki S, Kamada T, Fujiwara N, Nakano T, Tomita H, Matsunaga T, Magota K, Okumura K . Circulating coupling factor 6 in human hypertension: role of reactive oxygen species. J Hypertens 2003; 21: 2323\u20132328.","journal-title":"J Hypertens"},{"key":"BFhr2012231_CR18","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1097\/HJH.0b013e32833dfcbe","volume":"28","author":"T Ashitate","year":"2010","unstructured":"Ashitate T, Osanai T, Tanaka M, Magota K, Echizen T, Izumiyama K, Yokoyama H, Shibutani S, Hanada K, Tomita H, Okumura K . Overexpression of coupling factor 6 causes cardiac dysfunction under high salt diet in mice. J Hypertens 2010; 28: 2243\u20132251.","journal-title":"J Hypertens"},{"key":"BFhr2012231_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/hr.2011.232","volume":"35","author":"K Izumiyama","year":"2012","unstructured":"Izumiyama K, Osanai T, Sagara S, Yamamoto Y, Itoh T, Sukekawa T, Nishizaki F, Magota K, Okumura K . Estrogen attenuates coupling factor 6-induced salt-sensitive hypertension and cardiac systolic dysfunction in mice. Hypertens Res 2012; 35: 539\u2013546.","journal-title":"Hypertens Res"},{"key":"BFhr2012231_CR20","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00125-011-2341-z","volume":"55","author":"T Osanai","year":"2012","unstructured":"Osanai T, Tanaka M, Magota K, Tomita H, Okumura K . Coupling factor 6-induced activation of ecto-F1Fo complex induces insulin resistance, mild glucose intolerance and elevated blood pressure in mice. Diabetologia 2012; 55: 520\u2013529.","journal-title":"Diabetologia"},{"key":"BFhr2012231_CR21","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/HJH.0b013e3283505101","volume":"30","author":"S Sagara","year":"2012","unstructured":"Sagara S, Osanai T, Itoh T, Izumiyama K, Shibutani S, Hanada K, Yokoyama H, Yamamoto Y, Yokota T, Tomita H, Magota K, Okumura K . Overexpression of coupling factor 6 attenuates exercise-induced physiological cardiac hypertrophy by inhibiting PI3K\/Akt signaling in mice. J Hypertens 2012; 30: 778\u2013786.","journal-title":"J Hypertens"},{"key":"BFhr2012231_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0005-2728(93)90063-L","volume":"1140","author":"PD Boyer","year":"1993","unstructured":"Boyer PD . The binding change mechanism for ATP synthase: some probabilities and possibilities. Biochim Biophys Acta 1993; 1140: 215\u2013250.","journal-title":"Biochim Biophys Acta"},{"key":"BFhr2012231_CR23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/0022-2836(85)90313-4","volume":"184","author":"JE Walker","year":"1985","unstructured":"Walker JE, Fearnley IM, Gay NJ, Gibson BW, Northrop FD, Powell SJ, Runswick MJ, Saraste M, Tybulewicz VL . Primary structure and subunit stoichiometry of F1-ATPase from bovine mitochondria. J Mol Biol 1985; 184: 677\u2013701.","journal-title":"J Mol Biol"},{"key":"BFhr2012231_CR24","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.2337\/dc09-0584","volume":"32","author":"S Araki","year":"2009","unstructured":"Araki S, Matsuno H, Haneda M, Kyoya D, Kanno Y, Itho J, Kishi A, Isshiki K, Sugimoto T, Maegawa H, Kashiwagi A, Uzu T . Correlation between albuminuria and spontaneous platelet microaggregate formation in type 2 diabetic patients. Diabetes Care 2009; 32: 2062\u20132067.","journal-title":"Diabetes Care"},{"key":"BFhr2012231_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.thromres.2004.02.017","volume":"113","author":"G Di Minno","year":"2004","unstructured":"Di Minno G, Violi F . Aspirin resistance and diabetic angiopathy: back to the future. Thromb Res 2004; 113: 97\u201399.","journal-title":"Thromb Res"},{"key":"BFhr2012231_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","volume":"364","author":"HC Diener","year":"2004","unstructured":"Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ, MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): a randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 331\u2013337.","journal-title":"Lancet"},{"key":"BFhr2012231_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ahj.2004.03.028","volume":"148","author":"DL Bhatt","year":"2004","unstructured":"Bhatt DL, Topol EJ . Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J 2004; 148: 263\u2013268.","journal-title":"Am Heart J"},{"key":"BFhr2012231_CR28","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1172\/JCI108841","volume":"60","author":"IF Charo","year":"1977","unstructured":"Charo IF, Feinman RD, Detwiler TC . Interrelations of platelet aggregation and secretion. J Clin Invest 1977; 60: 866\u2013873.","journal-title":"J Clin Invest"},{"key":"BFhr2012231_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJM199001043220107","volume":"322","author":"BS Coller","year":"1990","unstructured":"Coller BS . Platelet and thrombolytic therapy. N Engl J Med 1990; 322: 33\u201342.","journal-title":"N Engl J Med"},{"key":"BFhr2012231_CR30","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1074\/jbc.273.4.2024","volume":"273","author":"JL Daniel","year":"1998","unstructured":"Daniel JL, Dangelmaier C, Jin J, Ashby B, Smith JB, Kunapuli SP . Molecular basis for ADP-induced platelet activation I: evidence for three distinct ADP receptors on platelets. J Biol Chem 1998; 273: 2024\u20132029.","journal-title":"J Biol Chem"},{"key":"BFhr2012231_CR31","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1172\/JCI12242","volume":"107","author":"CJ Foster","year":"2001","unstructured":"Foster CJ, Prosser DM, Agans JM, Zhai Y, Smith MD, Lachowicz JE, Zhang FL, Gustafson E, Monsma FJ, Wiekowski MT, Abbondanzo SJ, Cook DN, Bayne ML, Lira SA, Chintala MS . Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 2001; 107: 1591\u20131598.","journal-title":"J Clin Invest"},{"key":"BFhr2012231_CR32","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1046\/j.1365-2141.2000.02208.x","volume":"110","author":"RF Storey","year":"2000","unstructured":"Storey RF, Sanderson HM, White AE, May JA, Cameron KE, Heptinstall S . The central role of the P2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. Br J Haematol 2000; 110: 925\u2013934.","journal-title":"Br J Haematol"},{"key":"BFhr2012231_CR33","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S0006-2952(01)00760-2","volume":"62","author":"UR Schwarz","year":"2001","unstructured":"Schwarz UR, Walter U, Eigenthaler M . Taming platelets with cyclic nucleotides. Biochem Pharmacol 2001; 62: 1153\u20131161.","journal-title":"Biochem Pharmacol"},{"key":"BFhr2012231_CR34","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1055\/s-0037-1613099","volume":"87","author":"JM Manns","year":"2002","unstructured":"Manns JM, Brenna KJ, Colman RW, Sheth SB . Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases. Thromb Haemost 2002; 87: 873\u2013879.","journal-title":"Thromb Haemost"},{"key":"BFhr2012231_CR35","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1046\/j.1523-1755.2003.00334.x","volume":"64","author":"T Osanai","year":"2003","unstructured":"Osanai T, Nakamura M, Sasaki S, Tomita H, Saitoh M, Osawa H, Yamabe H, Murakami S, Magota K, Okumura K . Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease. Kidney Int 2003; 64: 2291\u20132297.","journal-title":"Kidney Int"},{"key":"BFhr2012231_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/07853890903451781","volume":"42","author":"T Osanai","year":"2010","unstructured":"Osanai T, Fujiwara N, Sasaki S, Metoki N, Saitoh G, Tomita H, Nishimura T, Shibitani S, Yokoyama H, Konta Y, Magota K, Okumura K . Novel pro-atherogenic molecule coupling factor 6 is elevated in patients with stroke: a possible linkage to homocysteine. Ann Med 2010; 42: 79\u201386.","journal-title":"Ann Med"},{"key":"BFhr2012231_CR37","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1291\/hypres.27.717","volume":"27","author":"WH Ding","year":"2004","unstructured":"Ding WH, Chu SY, Jiang HF, Cai DY, Pang YZ, Tang CS, Qi YF . Plasma mitochondrial coupling factor 6 in patients with acute myocardial infarction. Hypertens Res 2004; 27: 717\u2013722.","journal-title":"Hypertens Res"},{"key":"BFhr2012231_CR38","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ijcard.2006.05.051","volume":"117","author":"XL Li","year":"2007","unstructured":"Li XL, Xing QC, Gao YY, Dong B, Pang YZ, Jiang HF, Tang CS . Plasma level of mitochondrial coupling factor 6 increases in patients with type 2 diabetes mellitus. Int J Cardiol 2007; 117: 411\u2013412.","journal-title":"Int J Cardiol"},{"key":"BFhr2012231_CR39","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cardiores.2005.02.022","volume":"67","author":"H Tomita","year":"2005","unstructured":"Tomita H, Osanai T, Toki T, Sasaki S, Maeda N, Murakami R, Magota K, Yasujima M, Okumura K . Troglitazone and 15-deoxy-deta 12, 14-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells. Cardiovasc Res 2005; 67: 134\u2013141.","journal-title":"Cardiovasc Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr2012231.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2012231","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2012231.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:11:18Z","timestamp":1684429878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2012231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,7]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["BFhr2012231"],"URL":"https:\/\/doi.org\/10.1038\/hr.2012.231","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,7]]}}}